Physician profile
Cassandra Pinon
NPI 1770296287
$3,265.36
in general payments reported to CMS, 2019-2025
15 companies · $1,600 in 2025
The $1,600 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $534 · 2024: $1,131 · 2025: $1,600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,831 · Travel and Lodging: $434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,831.40 |
| Travel and Lodging | $433.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $1,328.50 | 2024-2025 | V.A.C. Veraflo, Bair Hugger, V.A.C. Veraflo Cleanse Choice |
| Melinta Therapeutics, LLC | $514.72 | 2023-2025 | Kimyrsa, Rezzayo, Orbactiv |
| Urgo Medical North America, LLC | $422.57 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Urgoclean Ag |
| Smith+Nephew, INC. | $259.37 | 2024-2025 | Collagenase Santyl, Oasis, Grafix Pl |
| Kci USA, INC. | $183.37 | 2023 | V.A.C. Veraflo Cleanse Choice, V.A.C. Veraflo, V.A.C. Dermatac |
| Organogenesis INC. | $137.23 | 2025 | Puraply Wound Matrix, Apligraf, Affinity |
| Paratek Pharmaceuticals, INC. | $104.27 | 2023-2025 | Nuzyra |
| Tactile Systems Technology INC | $98.89 | 2025 | Nimbl, Flexitouch Plus |
| Hydrofera LLC | $55.25 | 2023-2025 | Hydrofera Blue |
| Bard Peripheral Vascular, INC. | $46.61 | 2025 | Fluency Endovascular Stent Graft |
| Phadia US INC. | $29.66 | 2024 | Immunocap |
| Pfizer INC. | $23.61 | 2024 | |
| Hartmann USA, INC. | $20.79 | 2025 | Zetuvit Plus 10x10 P10 |
| Next Science LLC | $20.69 | 2023 | Blastx, Surgx, Xperience |
| Kerecis Limited | $19.83 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Pinon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.